# Patrick Schloemer

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/patrick-schloemer/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,964 |
| Field | Hormonal Regulation and Hypertension |
| h-index | 15 |
| i10-index | 19 |
| Last Known Institution | FIND |
| OpenAlex ID | https://openalex.org/A5046901330 |
| ORCID iD | 0009-0004-7787-5662 |
| Works | 75 |

## Researcher papers

- [Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes](https://scholariq.org/papers/effect-of-finerenone-on-chronic-kidney-disease-outcomes-in-type-2-diabetes/)
- [Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes](https://scholariq.org/papers/finerenone-and-cardiovascular-outcomes-in-patients-with-chronic-kidney-disease/)
- [Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial](https://scholariq.org/papers/design-and-baseline-characteristics-of-the-finerenone-in-reducing-kidney-failure/)
- [Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes](https://scholariq.org/papers/finerenone-in-heart-failure-and-chronic-kidney-disease-with-type-2-diabetes-fine/)
- [Finerenone in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Rationale and Design of the FINEARTS-HF Trial](https://scholariq.org/papers/finerenone-in-patients-with-heart-failure-with-mildly-reduced-or-preserved/)
- [Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial](https://scholariq.org/papers/design-and-baseline-characteristics-of-the-finerenone-in-addition-to-standard-of/)
- [Finerenone and Kidney Outcomes in Patients With Heart Failure](https://scholariq.org/papers/finerenone-and-kidney-outcomes-in-patients-with-heart-failure/)
- [Spinal High-Velocity Low Amplitude Manipulation in Acute Nonspecific Low Back Pain](https://scholariq.org/papers/spinal-high-velocity-low-amplitude-manipulation-in-acute-nonspecific-low-back/)
- [Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression](https://scholariq.org/papers/development-and-validation-of-a-new-hierarchical-composite-end-point-for/)
- [Validity and Utility of a Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression: A Review](https://scholariq.org/papers/validity-and-utility-of-a-hierarchical-composite-end-point-for-clinical-trials/)
- [Finerenone in Persons with Chronic Kidney Disease without Diabetes](https://scholariq.org/papers/finerenone-in-persons-with-chronic-kidney-disease-without-diabetes/)

## Researcher topics

- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Researcher university

- [FIND](https://scholariq.org/institutions/find/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.